CAMBRIDGE, Mass., April 25, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the first quarter ended March 31, 2011 before the U.S. financial markets open on Thursday, May 5, 2011.
